Hoxton Planning & Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $437K | Sell |
18,039
-6,710
| -27% | -$163K | 0.15% | 115 |
|
|
2025
Q1 | $627K | Sell |
24,749
-6,392
| -21% | -$162K | 0.24% | 83 |
|
|
2024
Q4 | $826K | Buy |
31,141
+3,874
| +14% | +$103K | 0.32% | 63 |
|
|
2024
Q3 | $789K | Buy |
27,267
+1,424
| +6% | +$41.2K | 0.31% | 60 |
|
|
2024
Q2 | $723K | Buy |
25,843
+9,115
| +54% | +$255K | 0.34% | 54 |
|
|
2024
Q1 | $464K | Buy |
16,728
+7,097
| +74% | +$197K | 0.22% | 88 |
|
|
2023
Q4 | $277K | Sell |
9,631
-1,768
| -16% | -$50.9K | 0.15% | 113 |
|
|
2023
Q3 | $378K | Buy |
11,399
+1,884
| +20% | +$62.5K | 0.24% | 81 |
|
|
2023
Q2 | $349K | Sell |
9,515
-402
| -4% | -$14.7K | 0.22% | 93 |
|
|
2023
Q1 | $405K | Buy |
9,917
+78
| +0.8% | +$3.18K | 0.22% | 92 |
|
|
2022
Q4 | $504K | Buy |
+9,839
| New | +$504K | 0.27% | 75 |
|